UPL to Raise Up to USD 500 Million in Forthcoming Rights Issue

Agrochemical giant UPL Ltd announced on Monday its plans to raise up to USD 500 million (approximately Rs 4200 crore) through a Rights Issue, as confirmed by the company's Chief Financial Officer (CFO), Anand Vora, during a media briefing following the announcement of their fourth-quarter earnings. The move, which has already received the green light from the company's board, is anticipated to make its market debut by the early third quarter of this fiscal year.

Representative image

Vora highlighted that the final decision regarding the exact size of the Rights Issue will be determined closer to its launch, based on prevailing market conditions and pricing strategies. He also noted that the Securities and Exchange Board of India (SEBI) has directed UPL Ltd to follow the standard procedure for such financial exercises, which typically spans 90 to 135 days before the issue can be presented to the market. The company is poised to file its Draft Red Herring Prospectus (DRHP) imminently in line with these requirements.

In addition to its fundraising efforts, UPL Ltd is embarking on an ambitious capital expenditure (Capex) plan. The company has earmarked USD 210 million (about Rs 17000-18000 crore) for capacity expansion and investments in its seed, crop protection, and specialty chemicals businesses. This strategic allocation is aimed at bolstering the company's operational capabilities and market reach.

According to Vora, of the total Capex, approximately USD 80 million will be allocated towards tangible assets such as capacity expansion. The remainder will be invested in intangible assets crucial for product registration and other strategic areas within the seed, crop protection, and specialty chemicals sectors. This planned expenditure underscores UPL Ltd's commitment to reinforcing its position in the agrochemical industry while enhancing its product offerings and operational efficiency.

The CFO also revealed that while UPL Ltd had initially budgeted Rs 4000 crore for Capex in FY23, actual spending was curtailed to about Rs 2000 crore. This prudent management of resources reflects the company's strategic approach to investment and growth, ensuring that it remains well-positioned to capitalize on future opportunities.

UPL Ltd's decision to proceed with a Rights Issue and its substantial Capex plan are indicative of the company's long-term growth strategy and commitment to maintaining a competitive edge in the global agrochemical market. As these initiatives unfold, stakeholders and investors will keenly watch the impact on UPL Ltd's market performance and operational capabilities.